BCompany · Healthtech & Bio
BIOM
BIOM (BioInspired Materials) is a Barcelona-based biotech company founded in 2019 as a spin-off of Pompeu Fabra University, developing biotechnological solutions based on living microorganisms, bioactive molecules and novel biomaterials for agriculture and industry, including products like Nanulose (bacterial cellulose) and Ficogenic Broth (a bacterial culture medium). In May 2025 the company closed a €750,000 (~$842K) seed round led by BeAble Capital to scale industrial production alongside manufacturing partner Reactivos para Diagnóstico (RPD).
Founded
2019
Founders
3
News
0
Rounds
1
Investors
1
SectorsBiotechnology, Biomaterials, Agtech, Industrial biotech, Sustainability
Start-up MapHealthtech & Bio › R&D tools & software for life sciences
Profile updated 31 Jul 2026
Founders
C
Carlos Rodríguez-Caso
Founder Partner, Advisor
J
Javier Macía
CTO, Founder Partner
R
Ramón Farré-Escofet
Founder Partner, Advisor
Global models 5
GGinkgo Bioworks
United States · www.ginkgobioworks.com ↗
Synthetic biology platform engineering microorganisms to produce biomaterials and bio-based products at industrial scale, similar to BIOM's microorganism-based product development model.
$800MComparable
ZZymergen
United States · www.zymergen.com ↗
Biofacturing company that used microbial engineering to create novel biomaterials for industrial applications, directly comparable to BIOM's biomaterials-from-microorganisms approach.
$974MComparable
SSolugen
United States · www.solugen.com ↗
Uses fermentation and enzymatic processes to convert biomass into industrial chemicals, paralleling BIOM's biotech-driven, sustainable industrial product manufacturing.
$642MComparable
B
Bolt Threads
United States · boltthreads.com ↗
Develops biomaterials (mycelium- and protein-based) as sustainable alternatives to conventional materials, matching BIOM's biomaterials innovation focus.
$284MComparable
MModern Meadow
United States · www.modernmeadow.com ↗
Biofabricates sustainable materials using biotechnology and fermentation, aligning with BIOM's mission of producing biomaterials without conventional industrial waste.
$132MComparable
Investors 1
Funding rounds 1
News & media
No coverage on record yet.
